the breast trang 7 tải miễn phí từ TAILIEUCHUNG

"the breast" trang 7 - tải miễn phí từ Tailieuchung

It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature

It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature

8 22 1

Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence

Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence

8 35 1

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

7 41 1

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

7 67 1

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC

11 38 1

BRCA2 carriers with male breast cancer show elevated tumour methylation

BRCA2 carriers with male breast cancer show elevated tumour methylation

11 71 1

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

10 31 1

MiR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triplenegative breast cancer

MiR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triplenegative breast cancer

13 28 1

Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer

Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer

10 57 1

Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

16 54 1

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer

21 85 1

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway

11 79 1

Effect of neoadjuvant therapy on breast cancer biomarker profile

9 38 1

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer

13 63 1

Tamoxifen reverses epithelial – mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

Tamoxifen reverses epithelial – mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

12 37 1

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy

11 81 1

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

9 59 1

Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells

Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells

16 73 1

Development of nomograms to predict axillary lymph node status in breast cancer patients

Development of nomograms to predict axillary lymph node status in breast cancer patients

10 22 1

Detection of IKKε by immunohistochemistry in primary breast cancer: Association with EGFR expression and absence of lymph node metastasis

Detection of IKKε by immunohistochemistry in primary breast cancer: Association with EGFR expression and absence of lymph node metastasis

9 33 1

Đầu
1
2
3
4
5
6
[ 7 ]
8
9
10
11
12
13
14
15
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.